Export 1930 results:
Author Title Type [ Year(Asc)]
Belzeaux R, Fiori LM, Lopez JPablo, Boucekine M, Boyer L, Blier P, Farzan F, Frey BN, Giacobbe P, Lam RW et al..  2019.  Predicting Worsening Suicidal Ideation With Clinical Features and Peripheral Expression of Messenger RNA and MicroRNA During Antidepressant Treatment.. J Clin Psychiatry. 80(3)
Sapkota RP, Brunet A, Kirmayer LJ.  2019.  Predictors of Dissociative Experiences Among Adolescents in Nepal: A Path Analysis.. J Nerv Ment Dis.
Gabet M, Grenier G, Cao Z, MJ Fleury.  2019.  Predictors of Emergency Department Use among Individuals with Current or Previous Experience of Homelessness.. Int J Environ Res Public Health. 16(24)
Simo B, Caron J., Bamvita JM, Grenier G, MJ Fleury.  2019.  Predictors of Number of Healthcare Professionals Consulted by Individuals with Mental Disorders or High Psychological Distress.. Int J Environ Res Public Health. 16(17)
Miguel PMaidana, Pereira LOrlandi, Barth B, Filho EJosé de M, Pokhvisneva I, Nguyen TTT, Garg E, Razzolini BRegis, Koh DXin Ping, Gallant H et al..  2019.  Prefrontal Cortex Dopamine Transporter Gene Network Moderates the Effect of Perinatal Hypoxic-Ischemic Conditions on Cognitive Flexibility and Brain Gray Matter Density in Children.. Biol Psychiatry.
Corbett B, M Rajah N, Duarte A.  2019.  Preparing for the Worst: Evidence that Older Adults Proactively Downregulate Negative Affect.. Cereb Cortex.
Sauvé G, Brodeur MB, Shah JL, Lepage M.  2019.  The Prevalence of Negative Symptoms Across the Stages of the Psychosis Continuum.. Harv Rev Psychiatry. 27(1):15-32.
Gentil L, Grenier G, Bamvita JM, Dorvil H, MJ Fleury.  2019.  Profiles of Quality of Life in a Homeless Population. Frontiers in Psychiatry. 10(10):1-10.
MJ Fleury, Grenier G, Bamvita JM.  2019.  Profiles of Service Users with Severe Mental Disorders Based on Adequacy of Help.. Psychiatr Q. 90(3):613-627.
Ndibu Muntu Keba Kebe N, Chiocchio F, Bamvita JM, MJ Fleury.  2019.  Profiling mental health professionals in relation to perceived interprofessional collaboration on teams.. SAGE Open Med. 7:2050312119841467.
Lutgens D, Joober R, Iyer S, Lepage M, Norman R, Schmitz N, Mustafa S, Abadi S, Malla A.  2019.  Progress of negative symptoms over the initial 5 years of a first episode of psychosis.. Psychol Med. 49(1):66-74.
Olsen RK, Carr VA, Daugherty AM, La Joie R, Amaral RSC, Amunts K, Augustinack JC, Bakker A, Bender AR, Berron D et al..  2019.  Progress update from the hippocampal subfields group.. Alzheimers Dement (Amst). 11:439-449.
Zhang XMin, François U, Silm K, Angelo MFlorencia, Fernandez-Busch MVictoria, Maged M, Martin C, Bernard V, Cordelières FP, Deshors M et al..  2019.  A proline-rich motif on VGLUT1 reduces synaptic vesicle super-pool and spontaneous release frequency.. Elife. 8
Picard C, Poirier A, Bélanger S, Labonte A, Auld D, Poirier J.  2019.  Proprotein convertase subtilisin/kexin type 9 (PCSK9) in Alzheimer's disease: A genetic and proteomic multi-cohort study.. PLoS One. 14(8):e0220254.
Dong M, Lu L, Zhang L, Zhang Y-S, Ng CH, Ungvari GS, Li G, Meng X, Wang G, Xiang Y-T.  2019.  Quality of Life in Schizophrenia: A Meta-Analysis of Comparative Studies.. Psychiatr Q.
Schirrmacher R, Bailey JJ, Mossine AV, Scott PJH, Kaiser L, Bartenstein P, Lindner S, Kaplan DR, Kostikov A, Fricker G et al..  2019.  Radioligands for Tropomyosin Receptor Kinase (Trk) Positron Emission Tomography Imaging.. Pharmaceuticals (Basel). 12(1)
Wang JL, MacQueen G, Patten S, Manuel D, Lashewicz B, Schmitz N.  2019.  A randomized controlled trial to examine the impacts of disclosing personalized depression risk information on the outcomes of individuals who are at high risk of developing major depression: a research protocol.. BMC Psychiatry. 19(1):285.
Ng KPin, Therriault J, Kang MSu, Struyfs H, Pascoal TA, Mathotaarachchi S, Shin M, Benedet AL, Massarweh G, Soucy J-P et al..  2019.  Rasagiline, a monoamine oxidase B inhibitor, reduces in vivo [F]THK5351 uptake in progressive supranuclear palsy.. Neuroimage Clin. 24:102091.
Yung AR, Wood SJ, Malla A, Nelson B, McGorry P, Shah J.  2019.  The reality of at risk mental state services: a response to recent criticisms.. Psychol Med. :1-7.
Mustafa S, Bougie J, Miguelez M, Clerzius G, Rampakakis E, Proulx J, Malla A.  2019.  Real-life assessment of aripiprazole monthly (Abilify Maintena) in schizophrenia: a Canadian naturalistic non-interventional prospective cohort study.. BMC Psychiatry. 19(1):114.
MJ Fleury, Grenier G, Farand L, Ferland F.  2019.  Reasons for Emergency Department Use among Patients with Mental Disorders.. Psychiatr Q. 90:703-716.
Whitley R, Shepherd G, Slade M.  2019.  Recovery colleges as a mental health innovation.. World Psychiatry. 18(2):141-142.
Robinson M-E, Simard M, Larocque I, Shah J, Nakhla M, Rahme E.  2019.  Risk of Psychiatric Disorders and Suicide Attempts in Emerging Adults With Diabetes.. Diabetes Care.
Guma E, Rocchetti J, Devenyi GA, Tanti A, Mathieu AP, Lerch JP, Elgbeili G, Courcot B, Mechawar N, M Chakravarty M et al..  2019.  Role of D3 dopamine receptors in modulating neuroanatomical changes in response to antipsychotic administration.. Sci Rep. 9(1):7850.
Konsztowicz S, Lepage M.  2019.  The role of illness engulfment in the association between insight and depressive symptomatology in schizophrenia.. J Psychiatr Res. 111:1-7.